News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,803 Results
Type
Article (2421)
Company Profile (40)
Press Release (35342)
Section
Business (14118)
Career Advice (77)
Deals (2076)
Drug Delivery (8)
Drug Development (4097)
Employer Resources (10)
FDA (429)
Job Trends (761)
News (20129)
Policy (1050)
Tag
Academia (144)
Alliances (3464)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (14)
Approvals (431)
Bankruptcy (11)
Best Places to Work (475)
Biosimilars (10)
Biotechnology (30)
Breast cancer (15)
Cancer (104)
Career advice (64)
CAR-T (12)
Cell therapy (35)
Clinical research (3146)
Collaboration (79)
Compensation (36)
COVID-19 (180)
C-suite (21)
Data (82)
Diagnostics (461)
Duchenne muscular dystrophy (9)
Earnings (4166)
Events (5934)
Executive appointments (75)
FDA (466)
Funding (67)
Gene editing (13)
Gene therapy (13)
GLP-1 (59)
Government (146)
Healthcare (701)
Infectious disease (185)
Inflammatory bowel disease (11)
Intellectual property (9)
IPO (987)
Job creations (290)
Job search strategy (62)
Layoffs (36)
Legal (212)
Lung cancer (15)
Manufacturing (17)
Medical device (304)
Medtech (304)
Mergers & acquisitions (1141)
Metabolic disorders (27)
Neuroscience (81)
NextGen: Class of 2025 (353)
Non-profit (153)
Northern California (291)
Obesity (13)
Opinion (14)
Patents (14)
People (5598)
Phase I (1354)
Phase II (1586)
Phase III (838)
Pipeline (45)
Postmarket research (30)
Preclinical (582)
Radiopharmaceuticals (12)
Rare diseases (17)
Real estate (419)
Regulatory (789)
Research institute (143)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (20)
Southern California (284)
Startups (487)
United States (1385)
Vaccines (24)
Weight loss (9)
Date
Today (1)
Last 7 days (59)
Last 30 days (177)
Last 365 days (2555)
2025 (327)
2024 (2613)
2023 (2873)
2022 (3762)
2021 (4050)
2020 (3475)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Arizona (14)
Asia (1846)
Australia (295)
California (664)
Canada (120)
China (32)
Colorado (15)
Connecticut (9)
Europe (3793)
Florida (39)
Illinois (13)
Indiana (26)
Kansas (12)
Maryland (22)
Massachusetts (234)
Minnesota (14)
New Jersey (48)
New York (38)
North Carolina (80)
Northern California (291)
Ohio (24)
Pennsylvania (31)
South America (40)
Southern California (284)
Texas (54)
Washington State (36)
37,803 Results for "annexon biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
Annexon Biosciences to Present at the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - February 18, 2025
February 19, 2025
·
1 min read
Biotech Bay
Annexon Biosciences to Present at the Bank of America 2024 Health Care Conference
Annexon, Inc. announced that Douglas Love, president and chief executive officer, will present at the Bank of America Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT.
May 9, 2024
·
1 min read
Press Releases
Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year
January 14, 2025
·
7 min read
Business
Annexon Biosciences to Participate in Upcoming September Investor Conferences
August 29, 2024
·
1 min read
Press Releases
Annexon Expands Board of Directors with Appointment of Commercial Executive William “BJ” Jones
January 13, 2025
·
5 min read
Drug Development
Annexon’s Pivotal Phase III GBS Trial Hits Goal, Tees Up Approval Filing
Annexon’s late-stage Guillain-Barré syndrome trial has hit its primary endpoint and laid the foundation for a filing for approval next year, the company said Tuesday.
June 4, 2024
·
2 min read
·
Nick Paul Taylor
Press Releases
Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting
February 14, 2025
·
7 min read
Opinion: Annexon Tackles Guillain-Barre, Other Inflammatory Diseases with Novel Antibody
With Phase III trial results looming in the second quarter of 2024, Annexon Biosciences aims to transform treatment for Guillain-Barre syndrome with its investigational antibody, ANX005. The candidate is also being trialed in Huntington disease and ALS.
May 21, 2024
·
3 min read
·
Jia Jie Chen
1 of 3,781
Next
